The coronavirus probably shows patents to be a thorny mechanism for innovation. Pfizer might have a vax patent but then can't freely make money of it. If there were no patents, but they were the best manufacturers, might have been easier to have a freer market on it.
Patents necessarily put more capital investments into patentable work than unpatentable work, but that doesnt mean it is more efficient. I understand the principle of patents, but eventually you end up in heavy interventionism, state funding, litigation, etc. Best to do away of all of that imo.
And how much of the expenditure goes anywhere useful? And remember that they're incentivized to report 15% of their revenue being spent on R&D for tax reasons.
That $100B is just for drugs that later got FDA approval, not the NIH grant budget.
If you’re going to make that argument, you also have to consider the opposite possibility: I’ve worked on (non-medical) projects with public funding in the past. One can only hope that my experience wasn’t representative for the amount waste of public money in the medical world.
That’s a decent chunk of money, but it’s important to put it in perspective. Pfizer alone spends around $10B per year on R&D. J&J: $12B. Merck: $13B.